Trupanion sees improved profitability and free cash flow, raising its price target to $45. See why TRUP shares are rated a hold.

Bausch Health's Aplenzin could revolutionize TRD care, addressing a $3B market opportunity while aiding BHC stock's financial ...

General Dynamics is a strong buy. With a $90B backlog, defense growth, and expanding aerospace segments, see more on GD stock ...